Skip to main content
Terug
Watch Compare

FibroBiologics, Inc.

Datakwaliteit: 83%
FBLG
Nasdaq Manufacturing Chemicals
€ 1,35
▼ € 0,03 (-2,17%)
Marktkapitalisatie: 6,22 M
Prijs
€ 1,37
Marktkapitalisatie
6,22 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -16,66 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-3785,99%
Onder sectorgemiddelde (-53,47%)
ROIC-529,82%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio0,78
Interest Coverage-83,25

Waardering

PE (TTM)
-0,33
Boven sectorgemiddelde (-1,48)
P/B Ratio49,78
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,3 -1,5
P/B 49,8 1,6
ROE % -3786,0 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

3 analisten
Buy
Huidig
€ 1,35
+3085.2%
Koersdoel
€ 43,00
€ 19,00
€ 30,00
€ 80,00
Vooruitzicht
Forward K/W -0,25
Forward WPA -€ 5,40
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 5,40
-€ 7,60 – -€ 3,20
 0,0 2
FY2026 -€ 4,60
-€ 5,80 – -€ 3,40
 0,0 2

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 2,00 -€ 0,60 +70,0%
Q32025 -€ 2,30 -€ 2,60 -13,0%
Q22025 -€ 2,40 -€ 2,40 0,0%
Q12025 -€ 2,50 -€ 2,80 -12,0%

ETFs Holding This Stock

BRSIX BRSIX
0,07% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -18,65 M
ROE -3785,99% ROA -164,64%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -16,66 M
ROIC -529,82% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,78
Interest Coverage -83,25 Asset Turnover N/A
Working Capital -1,48 M Tangible Book Value 125.000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,33 Forward P/E N/A
P/B Ratio 49,78 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -267,69%
Market Cap 6,22 M Enterprise Value 1,36 M
Per Share
EPS (Diluted TTM) -0,42 Revenue / Share N/A
FCF / Share -3,67 OCF / Share -3,61
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89,33%
SBC-Adj. FCF -19,17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue — — —
Net Income -18,65 M -11,16 M -16,49 M
EPS (Diluted) -0,42 -0,34 -0,68
Gross Profit — — —
Operating Income -16,65 M -13,74 M -8,89 M
EBITDA — — —
R&D Expenses 7,41 M 4,50 M 2,37 M
SG&A Expenses — — —
D&A — — —
Interest Expense 200.000,0 20.000,0 147.000,0
Income Tax 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 9,62 M 16,45 M 11,82 M
Total Liabilities 3,46 M 13,71 M 10,57 M
Shareholders' Equity 6,16 M 2,74 M 1,25 M
Total Debt — 300.000,0 60.000,0
Cash & Equivalents 4,89 M 13,99 M 9,16 M
Current Assets 6,35 M 14,23 M 9,22 M
Current Liabilities 1,76 M 12,73 M 9,18 M